Åke Borg
201 – 210 of 394
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland
(
- Contribution to journal › Article
-
Mark
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
(
- Contribution to journal › Article
-
Mark
Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Genetic profiling differentiates second primary tumors from metastases in adult metachronous soft tissue sarcoma.
(
- Contribution to journal › Article
-
Mark
Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios.
(
- Contribution to journal › Article
-
Mark
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
(
- Contribution to journal › Article
-
Mark
Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes.
(
- Contribution to journal › Article
-
Mark
Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH).
(
- Contribution to journal › Article
-
Mark
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.
(
- Contribution to journal › Article
-
Mark
Variation of breast cancer risk among BRCA1/2 carriers
(
- Contribution to journal › Article